Evidence map›Paper›PMID 40107676›Full record

ArticleBMJ open2025

COVER-ME: developing and evaluating community-based interventions to promote vaccine uptake for COVID-19 and influenza in East London minority ethnicity (ME) and underserved individuals - protocol for a pilot randomised controlled trial.

Tahreem Chaudhry, Patricia Tum, Hui Zhen Tam, Adam Brentnall, Hector Smethurst, Karina Kielmann, Heinke Kunst, Sally Hargreaves, Colin N J Campbell, Chris Griffiths and 1 more

Registry-linked trialAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05866237 (COVER-ME), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05866237 nacompletednot on this map

COVER-ME: Covid-19 Vaccination Coverage Among Underserved Populations: Developing and Evaluating Community-based Interventions in East London Minority Ethnicity (ME) Populations; Underserved Migrants and Persons With Low Income.

TypeinterventionalSponsorQueen Mary University of LondonRan2023 to 2025Enrolled5,903ConditionsCOVID-19, Influenza, Vaccination RefusalArmsPatient Engagement tool
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tahreem ChaudhryWolfson Institute of Population Health, Queen Mary University of London, London, UK t_chaudhry@hotmail.co.uk.ORCID http://orcid.org/0000-0002-5245-3007
Patricia TumWolfson Institute of Population Health, Queen Mary University of London, London, UK.
Hui Zhen TamWolfson Institute of Population Health, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0002-8542-1749
Adam BrentnallWolfson Institute of Population Health, Queen Mary University of London, London, UK.
Hector SmethurstWolfson Institute of Population Health, Queen Mary University of London, London, UK.
Karina KielmannInstitute of Tropical Medicine, Antwerpen, Belgium.
Heinke KunstBlizard Institute, Queen Mary University London, London, UK.
Sally HargreavesSt. George's University of London, London, UK.
Colin N J CampbellImmunisations and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, UK.
Chris GriffithsWolfson Institute of Population Health, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0001-7935-8694
Dominik ZennerWolfson Institute of Population Health, Queen Mary University of London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionUnder-vaccination among underserved groups remains low due to existing disparities. This is particularly the case with postpandemic COVID-19 vaccinations and other vaccine-preventable diseases, including measles, mumps, rubella or influenza. Therefore, we aim to (1) determine the feasibility and practicality of implementing a patient engagement tool (PET) and gain vital insights to plan a subsequent definitive randomised controlled trial (RCT) to evaluate the effectiveness of this tool for increasing uptake of COVID-19 and influenza vaccinations and (2) define the appropriate level of support needed for healthcare providers at site-level to ensure successful implementation of the PET and to identify supporting activities needed to implement interventions for COVID-19 and influenza vaccinations. METHODS AND ANALYSIS: This is a randomised controlled feasibility study evaluating a co-designed PET, involving randomisation at individual and cluster levels. For individual randomisation, patients will be individually randomised 1:1 to receive the intervention (PET) or routine care; whereas for cluster randomisation, six GP (General Practitioner) practices will be randomised 1:1 and divided into two tranches at two separate time points. Both groups will receive training and software activation. Data will be analysed using statistical software R (V.4.0 or greater) or STATA (V.17 or greater). Baseline characteristics will be summarised and presented in groups based on an intention-to-treat basis with categorical data, including demographics, socioeconomic variables, comorbidities and vaccination status. ETHICS AND DISSEMINATION: Ethical approval was granted by the Westminster Ethics Committee (ref: 316860). Our dissemination strategy targets three audiences: (1) policy makers, public and health service managers, and clinicians responsible for delivering vaccines and infection prevention services; (2) patients and public from underserved population groups and (3) academics. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov (NCT05866237).

Indexed as

COVID-19COVID-19 VaccinesInfluenza, HumanInfluenza VaccinesMinority GroupsVaccinationEthnicityFeasibility StudiesHumansLondonPatient ParticipationPilot ProjectsRandomized Controlled Trials as TopicVulnerable PopulationsCOVID-19 VaccinesInfluenza VaccinesCOVID-19Health EquityHealth ServicesInfection controlVaccination

Identifiers

PMID40107676
PMCPMC11927436

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.